Sana Biotechnology Inc (NASDAQ:SANA) has a beta value of -36.65% and has seen 3.73 shares traded in the last trading session. The company, currently valued at $588.70M, closed the last trade at $2.76 per share which meant it lost -$6.57 on the day or 2.61% during that session. The SANA stock price is -168.12% off its 52-week high price of $7.40 and 54.35% above the 52-week low of $1.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.52 million shares traded. The 3-month trading volume is 3.13 shares.
The consensus among analysts is that Sana Biotechnology Inc (SANA) is Buy stock at the moment, with a recommendation rating of 57.21. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Sporting 2.61% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SANA stock price touched $2.76 or saw a rise of 7.07%. Year-to-date, Sana Biotechnology Inc shares have moved -56.50%, while the 5-day performance has seen it change 2.76%. Over the past 30 days, the shares of Sana Biotechnology Inc (NASDAQ:SANA) have changed 24.88%. Short interest in the company has seen 44.26 million shares shorted with days to cover at 11.67.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 65.5% from current levels. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -189.86% off the targeted high while a plunge would see the stock gain -189.86% from current levels.
Sana Biotechnology Inc (SANA) estimates and forecasts
The company’s shares have gained 33.16% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 18.55% -10.60% over the past 5 years. Earnings growth for 2025 is a modest 34.68% while over the next 5 years, the company’s earnings are expected to increase by 14.07%.
SANA Dividends
Sana Biotechnology Inc is expected to release its next earnings report on 2025-May-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
Insiders own 8.46% of the company shares, while shares held by institutions stand at 89.39% with a share float percentage of 97.65%. Investors are also buoyed by the number of investors in a company, with Sana Biotechnology Inc having a total of 225.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 27.17 million shares worth more than $148.35 million. As of 2024-06-30, FMR LLC held 11.5894% of shares outstanding.
The other major institutional holder is FLAGSHIP PIONEERING INC., with the holding of over 25.0 million shares as of 2024-06-30. The firm’s total holdings are worth over $136.51 million and represent 10.6645% of shares outstanding.
